Clinical Trial Update: Continuous Infusion of rhIL-15 for Adults With Advanced Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial updating continuous infusion of rhIL-15 in adults with advanced cancer; completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Carcinoma
• Lymphoma

Drugs mentioned

• rhIL-15 (recombinant human interleukin-15)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Lymphoma, Carcinoma | Phase 1 | Status: COMPLETED | Results posted: 2023-03-06